PBYI Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Zacks Investment Research - Mentions: IRWD ABBV

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?

21 days ago - By: Benzinga - Mentions: COGT IRWD AKBA SGRY ...

12 Health Care Stocks Moving In Monday's Intraday Session

24 days ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

24 days ago - By: Zacks Investment Research - Mentions: ANIP SNDX ARQT

PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised

25 days ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

25 days ago - By: Zacks Investment Research - Mentions: CUE

Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates

25 days ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Third Quarter 2025 Financial Results

26 days ago - By: Zacks Investment Research - Mentions: ACAD

Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top Estimates

a month ago - By: Puma Biotechnology, Inc.

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

2 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: ANIP CRMD

PBYI Surges 30% in 3 Months: How Should You Play the Stock?

3 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Zacks Investment Research

Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

3 months ago - By: Zacks Investment Research

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

4 months ago - By: Zacks Investment Research - Mentions: ADPT

Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?

4 months ago - By: Zacks Investment Research

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

4 months ago - By: Zacks Investment Research

Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?

4 months ago - By: Yahoo Finance

Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT

4 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Zacks Investment Research - Mentions: CRMD EXAS IMCR

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

4 months ago - By: The Motley Fool

Puma (PBYI) Q2 Revenue Rises 11%

4 months ago - By: Zacks Investment Research - Mentions: SPRB

Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates

4 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Second Quarter Financial Results

4 months ago - By: Zacks Investment Research - Mentions: ADMA

Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates

4 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results

5 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Zacks Investment Research

Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors

6 months ago - By: Zacks Investment Research

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

7 months ago - By: Zacks Investment Research

Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock

7 months ago - By: Zacks Investment Research

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?

7 months ago - By: Zacks Investment Research - Mentions: ANIP ADMA IMCR

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates

7 months ago - By: Zacks Investment Research - Mentions: KMDA

Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates

7 months ago - By: Puma Biotechnology, Inc..

Puma Biotechnology Reports First Quarter Financial Results

7 months ago - By: Zacks Investment Research - Mentions: PRGO NTLA ELEV

Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y

7 months ago - By: Zacks Investment Research - Mentions: JAZZ NTLA ELEV

PUMA BIOTECHNOLOGY INC (PBYI) Stock News

PBYI Latest News, Press Relases and Analysis

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?

12 Health Care Stocks Moving In Monday's Intraday Session

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised

Earnings Scheduled For November 6, 2025

Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates

Puma Biotechnology Reports Third Quarter 2025 Financial Results

Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top Estimates

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

PBYI Surges 30% in 3 Months: How Should You Play the Stock?

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?

Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

Puma (PBYI) Q2 Revenue Rises 11%

Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates

Puma Biotechnology Reports Second Quarter Financial Results

Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates

Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates

Puma Biotechnology Reports First Quarter Financial Results

Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook